NCR2 and neoplasm: We characterized one potential peptide, NKp44-derived pep8 (NKp44-pep8), which manifested a specific interaction with PCNA and blocked NKp44 binding to PCNA; upon fusion to cell-penetrating peptide (CPP), pep8 induced tumor cell death in vitro as well as tumor growth suppression in vivo.